Century Therapeutics Unveils Presentations At Key Medical Event
Innovative Presentations at ASGCT Annual Meeting
PHILADELPHIA — Century Therapeutics, Inc. (NASDAQ: IPSC), a pioneering name in biotechnology, is thrilled to announce its participation at the prestigious American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting. This event promises to be a significant gathering of innovators dedicated to advancing gene and cell therapies, scheduled to take place in mid-May at an influential venue.
Highlights of the Presentations
Century Therapeutics will present noteworthy findings that underline the progression of their preclinical cell therapy pipeline, specifically designed to address challenges posed by autoimmune diseases and cancer. Below are details regarding the impactful presentations scheduled.
First Presentation: Armored Allogeneic Therapies
Abstract Number: 1826
Poster Number: 740
Session Date/Time: Tuesday, May 13, time slots from 6:00 PM to 7:30 PM CDT
Presenter: Raisa Uchurova, Ph.D., a Principal Scientist at Century Therapeutics
This presentation will delve into a revolutionary technique where iPSC-derived allogeneic therapies are equipped with a neutralizing synthetic receptor aimed at significantly improving solid tumor elimination under conditions that mimic the tumor microenvironment. The ongoing research displays promising data that could revolutionize treatment strategies.
Second Presentation: CAR T Cells Generation
Abstract Number: 1857
Session Date/Time: Saturday, May 17, from 11:15 AM to 11:30 AM CDT
Presenter: Dar Heinze, M.D., Associate Director at Century Therapeutics
This segment will focus on generating iPSC-derived CD4+ and CD8+ CAR T cells engineered to combat tumors effectively. The preliminary findings indicate comparable tumor control and cell expansion to those seen in healthy donor T cells, showcasing a groundbreaking approach to enhancing cellular therapies.
About Century Therapeutics
Century Therapeutics (NASDAQ: IPSC) stands at the forefront of innovation in biotechnology. With a deep commitment to translating cellular reprogramming and genetic engineering into practical cell therapy solutions, they aim to cater to the pressing needs concerning autoimmune diseases and cancers. The company’s pipeline is designed to create accessible, off-the-shelf therapies, enhancing patient reach and potentially transforming existing treatment paradigms.
Engagement and Further Information
For those interested in exploring further details after the presentations, additional materials and accepted abstracts will be available under the Scientific Resources section on the company’s website. Century Therapeutics invites the audience to explore their ongoing work and connect with them for broader discussions.
Frequently Asked Questions
What are the main focus areas for Century Therapeutics?
Century Therapeutics primarily focuses on developing induced pluripotent stem cell-derived therapies for autoimmune diseases and cancers.
Where will the ASGCT Annual Meeting take place?
The ASGCT Annual Meeting is set to occur at the New Orleans Ernest N. Morial Convention Center.
When are the presentations scheduled?
The presentations are scheduled for May 13 and May 17, with specific time slots allocated for each session.
Who are the presenters for Century’s abstract submissions?
The presentations will be given by Raisa Uchurova, Ph.D., and Dar Heinze, M.D., both valued members of the Century Therapeutics team.
How can I learn more about Century Therapeutics?
You can learn more by visiting [www.centurytx.com](https://www.centurytx.com) and by following their updates on LinkedIn.
About The Author
Contact Hannah Lewis privately here. Or send an email with ATTN: Hannah Lewis as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
